Virus News and Research

Latest Virus News and Research

Study determines minimally effective dose of clinical candidate gene therapy vector to treat hemophilia A

Researchers determined the minimally effective dose (MED) of a clinical candidate gene therapy vector for treating hemophilia A.

16 Dec 2021

25 million people in the UK have had COVID-19 top up jab

More than 25 million people in the UK have had a COVID-19 top up jab, as the vaccination programme is turbocharged to get all eligible adults boosted as soon as possible.

16 Dec 2021

Antibody-like proteins derived from sharks may be used to combat future SARS outbreaks

Small, unique antibody-like proteins known as VNARs - derived from the immune systems of sharks - can prevent the virus that causes COVID-19, its variants, and related coronaviruses from infecting human cells, according to a new study published Dec. 16.

16 Dec 2021

NIH scientists highlight the urgent need for universal coronavirus vaccines

A growing body of scientific evidence, considered together with ecological reality, strongly suggest that novel coronaviruses will continue to infect bats and other animal reservoirs and potentially emerge to pose a pandemic threat to humans.

16 Dec 2021

KHN’s ‘What the Health?’: Oh, oh, omicron

This week, the U.S. passed the milestone of 800,000 dead from covid-19, as hospitals are starting to fill following the Thanksgiving holiday and the ominous omicron variant starts to spread rapidly.

16 Dec 2021

New study demonstrates SARS-CoV-2 Omicron antibody escape

A new study examined the neutralization of virus variants using three sets of antibodies: serum from individuals vaccinated or infected with earlier variants of the virus; concentrated human antibodies from plasma donors; and approved monoclonal antibodies.

16 Dec 2021

Moderna booster vaccination overcomes SARS-CoV-2 Omicron variant antibody escape

A new study reports the results of a study focused on immune evasion characteristics, specifically the ability to escape neutralization by antibodies to the earlier SARS-CoV-2 variants or to the spike antigen used in COVID-19 vaccines.

16 Dec 2021

Study suggests convalescent plasma appears safe but does not prevent SARS-CoV-2 infection

A new study assesses the safety and efficacy of SARS-CoV-2 convalescent plasma containing high titers of anti-SARS-CoV-2 antibodies as PEP.

16 Dec 2021

Gene key to excessive cell proliferation could be a potential target for fatal pulmonary hypertension

A gene that is overexpressed in some aggressive cancers also appears to be key to the excessive cell proliferation that thickens the walls of pulmonary arteries and ultimately causes the right ventricle of the heart to fail, scientists report.

16 Dec 2021

Researchers map how the HTLV-1 virus causes a rare leukemia in some people

An international team have mapped how the HTLV-1 virus causes a rare leukemia in some people, providing clues on how to stop it happening.

16 Dec 2021

Therapeutic antibodies deemed ineffective against Omicron variant of SARS-CoV-2

A new study found that the Omicron S protein evades antibodies with a 44-fold higher efficiency than the Delta variant's spike, rendering therapeutic antibodies ineffective and likely negatively impacting antibody protection induced by infection or double vaccination.

16 Dec 2021

Experimental and computational synergy considered a promising approach in COVID-19 patients

Thanks to the large amount of -omics data becoming increasingly available, sophisticated computational models are developed for new fields such as immunology and the predictions they generate will help identify key molecules in inflammatory processes.

16 Dec 2021

Neutralization potency of COVID-19 vaccine boosters against SARS-CoV-2 variant pseudoviruses

A new study has used this assay to evaluate sera, obtained from 239 individuals vaccinated via any of the above-stated vaccines against SARS-CoV-2’s original strain, the Delta, and Omicron SARS-CoV-2 pseudoviruses.

16 Dec 2021

Human monoclonal antibody protects against SARS-CoV-2 and SARS-CoV in vivo

Scientists identified a human monoclonal antibody (mAb), which successfully neutralized or bound all sarbecoviruses tested in vitro.

16 Dec 2021

Exploring the plasma neutralization properties of the Omicron variant of SARS-CoV-2

A new study determines the ability of individuals with varying exposure to SARS-CoV-2 infection and vaccination, to neutralize SARS- CoV-2 pseudotypes.

16 Dec 2021

Study suggests Omicron can be neutralized by BNT162b2 recipient sera optimally after three vaccine doses

Researchers from Westmead Hospital have been investigating the effect of a third dose on neutralizing antibody titres in already vaccinated individuals.

16 Dec 2021

Nurses in crisis over covid dig in for better work conditions

Nurses and health care workers across the country are finding strength in numbers and with labor actions not seen in years.

16 Dec 2021

After ‘truly appalling’ death toll in nursing homes, California rethinks their funding

About 1 in 8 Californians who have died of covid lived in a nursing home. They were among the state's most frail residents: nearly 9,400 mothers, fathers, grandparents, aunts and uncles whom Californians entrusted to a nursing home's care. An additional 56,275 confirmed covid cases among nursing home residents weren't fatal.

16 Dec 2021

Research provides reassuring data on the risk of heart inflammation after SARS-CoV-2 vaccination

A study published by The BMJ today provides more reassuring data on the risk of heart inflammation (myocarditis or myopericarditis) after mRNA vaccination against the covid-19 virus.

16 Dec 2021

Omicron is more transmissible but may have milder symptoms for many people, expert says

If the first reports coming out of South Africa are correct, Omicron might be more transmissible than the current dominant Covid-19 strain, Delta, but cause less severe symptoms for many people. A leading expert says that, if the new strain does turn out to be milder for some people, that creates a new set of problems.

16 Dec 2021

Virus News and Research

Latest Virus News and Research

Study determines minimally effective dose of clinical candidate gene therapy vector to treat hemophilia A

25 million people in the UK have had COVID-19 top up jab

Antibody-like proteins derived from sharks may be used to combat future SARS outbreaks

NIH scientists highlight the urgent need for universal coronavirus vaccines

KHN’s ‘What the Health?’: Oh, oh, omicron

New study demonstrates SARS-CoV-2 Omicron antibody escape

Moderna booster vaccination overcomes SARS-CoV-2 Omicron variant antibody escape

Study suggests convalescent plasma appears safe but does not prevent SARS-CoV-2 infection

Gene key to excessive cell proliferation could be a potential target for fatal pulmonary hypertension

Researchers map how the HTLV-1 virus causes a rare leukemia in some people

Therapeutic antibodies deemed ineffective against Omicron variant of SARS-CoV-2

Experimental and computational synergy considered a promising approach in COVID-19 patients

Neutralization potency of COVID-19 vaccine boosters against SARS-CoV-2 variant pseudoviruses

Human monoclonal antibody protects against SARS-CoV-2 and SARS-CoV in vivo

Exploring the plasma neutralization properties of the Omicron variant of SARS-CoV-2

Study suggests Omicron can be neutralized by BNT162b2 recipient sera optimally after three vaccine doses

Nurses in crisis over covid dig in for better work conditions

After ‘truly appalling’ death toll in nursing homes, California rethinks their funding

Research provides reassuring data on the risk of heart inflammation after SARS-CoV-2 vaccination

Omicron is more transmissible but may have milder symptoms for many people, expert says

A new way of characterising biomolecules eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Newsletters you may be interested in